6974-14-7

Basic information

• Product Name: (2E)-2-[(4-methyl-2,5-dioxoimidazolidin-4-yl)methylidene]hydrazinecarbothioamide
• CAS NO: 6974-14-7
• Molecular Formula: C₆H₉N₅O₂S
• Molecular Weight: 215.233
• Mol File: 6974-14-7.mol
• Article Data: 0

Chemical Properties

• Density: 1.735g/cm³
• Refractive Index: 1.762
• CAS DataBase Reference: (2E)-2-[(4-methyl-2,5-dioxoimidazolidin-4-yl)methylidene]hydrazinecarbothioamide(CAS DataBase Reference)
• NIST Chemistry Reference: (2E)-2-[(4-methyl-2,5-dioxoimidazolidin-4-yl)methylidene]hydrazinecarbothioamide(6974-14-7)
• EPA Substance Registry System: (2E)-2-[(4-methyl-2,5-dioxoimidazolidin-4-yl)methylidene]hydrazinecarbothioamide(6974-14-7)

Safety Data

• Hazardous Substances Data: 6974-14-7(Hazardous Substances Data)

Usage

Description

(2E)-2-[(4-methyl-2,5-dioxoimidazolidin-4-yl)methylidene]hydrazinecarbothioamide is a hydrazine derivative with the molecular formula C6H9N5OS. It features a carbothioamide group, which consists of a sulfur atom double-bonded to a carbon atom, and an imidazolidine ring, a five-membered ring with two nitrogen atoms. (2E)-2-[(4-methyl-2,5-dioxoimidazolidin-4-yl)methylidene]hydrazinecarbothioamide also includes a methyl group and a dioxo group in the imidazolidine ring, contributing to its overall structure and reactivity. This unique structure makes it an interesting target for further study in the field of organic chemistry, with potential applications in organic synthesis and pharmaceuticals.

Uses

Used in Organic Synthesis:
(2E)-2-[(4-methyl-2,5-dioxoimidazolidin-4-yl)methylidene]hydrazinecarbothioamide is used as a synthetic building block for the creation of various organic compounds. Its unique structure and functional groups allow for versatile reactions and the formation of a wide range of products.
Used in Pharmaceutical Industry:
(2E)-2-[(4-methyl-2,5-dioxoimidazolidin-4-yl)methylidene]hydrazinecarbothioamide is used as a potential pharmaceutical agent due to its unique structure and functional groups. (2E)-2-[(4-methyl-2,5-dioxoimidazolidin-4-yl)methylidene]hydrazinecarbothioamide may be further studied and modified to develop new drugs with specific therapeutic properties.
While more research is needed to fully understand the properties and potential uses of this compound, its unique structure and functional groups make it a promising candidate for applications in both organic synthesis and the pharmaceutical industry.